Overview

Gender

male

Hervé Brailly was previously a researcher at Immunotech SA, a biotechnology start up acquired in 1995 by Beckman-Coulter (1986-1994), and then in charge of marketing, business development and R&D, as well as the business activities in China (1994-1998). Beginning in 1998, Mr Brailly was the director of a business unit of the company with 65 employees, with annual sales of 30 million U.S. dollars.

Hervé Brailly is also treasurer of BioCluster Eurobiomed which brings together companies in life sciences and technologies in the PACA region, and is a member of the Board of Directors of INSERM Transfert and of France Biotech.Hervé Brailly is a graduate of the Ecole des Mines de Paris (1983) and a Doctor of Immunology, with a specialization in immuno-pharmacology.